A Preview Of Brainstorm Cell’s Earnings
Brainstorm Cell (NASDAQ:BCLI) is set to give its latest quarterly earnings report on Thursday, 2023-03-30. Here’s what investors…
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider.
BrainStorm Cell Therapeutics Announces Promotion Of Dr. Stacy Lindborg To Co-Chief Executive Officer
BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the promotion of Dr. Stacy Lindborg to the role of Co-Chief
BrainStorm Cell Therapeutics Announces Type A Meeting With FDA Granted For NurOwn; Meeting Scheduled For Jan. 11, 2023
NEW YORK, Dec. 27, 2022 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that the U.S.
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Brainstorm Cell (NASDAQ:BCLI) stock moved upwards by 20.6% to $2.05 during Friday’s after-market session. The market value…
Veterans With ALS Who Support Co’s Request For The FDA To Hold A Public Advisory Committee Meeting To Engage In Scientific Discourse About The “Clinically Meaningful” Evidence Supporting FDA’s Approval Of A Mesenchymal Stem Cell Therapy, NurOwn
Veterans have a Significantly Increased Risk of 100% Fatal ALS, Caused by their Service for our Country
FDA Advisory Committee Meeting is Essential to Allow Veterans' Voices to be Heard about Need for
Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
Gainers
Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on Iberian Airlines' in-flight magazine, Ronda.
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's voluntary Chapter 11 petitions filed on November 7.